Compare Gigacloud Technology Inc (GCT) vs Nuwellis Inc (NUWE) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Gigacloud Technology Inc vs Nuwellis Inc — how do they compare? Gigacloud Technology Inc trades at $56.5 (market cap $2.00B), while Nuwellis Inc trades at $0.68 (market cap $2.20M). The key difference: Gigacloud Technology Inc is far larger — about 909.1× Nuwellis Inc's market cap, and Gigacloud Technology Inc is trading nearer its 52-week high, Nuwellis Inc nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Gigacloud Technology Inc for 21 Days and Nuwellis Inc for 26 Days on average.
| GCT | NUWE | |
|---|---|---|
Market Cap | $2.00B | $2.20M |
Volume | 1,000,927 | 121,544 |
Sector | Technology | Health |
52-Week High | $56.42 | $146.65 |
52-Week Low | $25.46 | $0.68 |
Typical Hold Time | 21 Days | 26 Days |
Enterprise Value | $2.13B | -$1.52M |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
GCT trades at $55.96, up 2.19% today, with a bullish technical signal from moving averages and strong fundamental performance. The company reported Q2 2026 EPS of $1.16, beating estimates of $0.90, continuing a trend of earnings beats. Revenue grew to $1.29 billion in 2025, with net income of $137.37 million and a healthy net margin of 10.65%. The stock is supported by positive cash flow from operations of $190.66 million in 2025.
The outlook for GCT is positive, driven by consistent earnings outperformance and robust profitability metrics like a 32.34% ROE. Risks include potential overbought conditions with an RSI of 72.38 and insider selling activity. Analyst consensus is bullish with a $32.50 price target, though the current price exceeds this, suggesting cautious optimism amid growth execution.
NUWE trades at $0.6907, down 1.48% on the day, with a bearish technical signal from moving averages despite oversold RSI readings. The company reported revenue growth to $9M in 2026 but remains deeply unprofitable with a net income margin of -125.63%. Recent news highlights console sales growth and strategic expansions in pediatric and critical care markets.
The outlook is high-risk due to persistent losses and negative cash flow, though analyst sentiment is split with a 50% buy rating. Investment potential hinges on the company's ability to achieve profitability and scale its Aquadex platform, while risks include cash burn and competitive pressures in the medical device sector.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Gigacloud Technology Inc
Gigacloud Technology operates a global B2B e-commerce marketplace for large-parcel goods. It provides a comprehensive solution for furniture manufacturers and retailers with integrated logistics and fulfillment.
Read more on GCT →About Nuwellis Inc
Nuwellis, Inc. is a medical device company focused on developing and commercializing fluid management solutions. The company's primary product is an ultrafiltration system used in hospitals to remove excess fluid from patients with fluid overload, often associated with conditions such as heart and kidney failure. Nuwellis aims to improve patient outcomes and reduce healthcare costs through its specialized, innovative therapies.
Read more on NUWE →
